Sung-Hye Grieco
Head of Process Development, MFG Platform Readiness Team Lead at Nutcracker Therapeutics, Inc. - Oakland, CA, US
Sung-Hye Grieco's Colleagues at Nutcracker Therapeutics, Inc.
Sung-Hye Grieco's Contact Details
N/A
United States
Nutcracker Therapeutics, Inc.
Sung-Hye Grieco's Company Details
Nutcracker Therapeutics is an early stage biotech disrupter founded to develop mRNA-based therapeutic drug products which will be manufactured on our novel ACORN (Automation COntroled RNA) microfluidic based manufacturing system. ACORN is a fully automated, software-controlled microfluidics platform. Our advanced technology-driven approach to therapeutics manufacturing addresses significant challenges associated with production and scale-up of therapeutic products. Automation and microfluidics deliver significantly reduced production cycle times, increased process control, efficiency and reproducibility while greatly reducing manual manipulations, risks of contamination and costly facilities. Through the introduction of breakthrough therapeutic micro factories, Nutcracker is poised to deliver on our mission to significantly improve patient's lives.